MRPL37 and neoplasm: Further, tumor stemness analysis showed that the mRNAsi score was significantly higher in the MRPL37 high-expression group, suggesting its association with enhanced tumor stemness and resistance to chemotherapy and radiotherapy (Figure S2B).